OBJECTIVE-To characterize the voltage-gated ion channels in human ␤-cells from nondiabetic donors and their role in glucosestimulated insulin release.
ϩ currents with TTX reduced glucose-stimulated (6 -20 mmol/l) insulin secretion by 55-70%. Human ␤-cells are equipped with L-(Ca V 1.3), P/Q-(Ca V 2.1), and T-(Ca V 3.2), but not N-or R-type Ca 2ϩ channels. Blockade of L-type channels abolished glucosestimulated insulin release, while inhibition of T-and P/Q-type Ca 2ϩ channels reduced glucose-induced (6 mmol/l) secretion by 60 -70%. Membrane potential recordings suggest that L-and T-type Ca 2ϩ channels participate in action potential generation. Blockade of P/Q-type Ca 2ϩ channels suppressed exocytosis (measured as an increase in cell capacitance) by Ͼ80%, whereas inhibition of L-type Ca 2ϩ channels only had a minor effect.
CONCLUSIONS-Voltage-gated T-type and L-type Ca 2ϩ channels as well as Na
ϩ channels participate in glucose-stimulated electrical activity and insulin secretion. Ca 2ϩ -activated BK channels are required for rapid membrane repolarization. Exocytosis of insulin-containing granules is principally triggered by Ca 2ϩ influx through P/Q-type Ca 2ϩ channels. Diabetes 57:1618-1628, 2008 V oltage-gated plasmalemmal ion channels play a fundamental role in stimulus secretion coupling in ␤-cells, and Ca 2ϩ influx through voltage-gated Ca 2ϩ channels triggers exocytosis of insulin-containing secretory granules (1) . Voltage-gated Ca 2ϩ channels are activated by coordinated fluctuations of the cell membrane potential (electrical activity), which are initiated by the glucose-induced closure of ATP-sensitive K ϩ channels (K ATP channels) (2, 3) and dependent on voltagegated Na ϩ and K ϩ channels (4) . Due to the limited availability of human islets, few electrophysiological studies of voltage-gated ion channels in human ␤-cells have been published, and the identity of the ␤-cells was not unequivocally established (5) (6) (7) (8) , although 45% of normal human islets cells are non-␤-cells (9) . In some earlier studies (10 -12) , identification of ␤-cells was based on the presence of K ATP currents. However, this is not unproblematic, as K ATP channels are also found in non-␤-cells (13, 14) .
In the present study, we have identified the voltagegated ion channels expressed in human ␤-cells obtained from nondiabetic donors and characterized their role in glucose-induced insulin secretion. Our data illustrate that human ␤-cells differ from rodent cells in several important respects.
RESEARCH DESIGN AND METHODS
Islet isolation and cell culture. With appropriate ethical approval and clinical consent, pancreatic islets were isolated in the Diabetes Research and Wellness Foundation Human Islet Isolation Facility from human pancreata retrieved from nondiabetic, heart-beating donors. This study is based on 34 islet preparations. For patch-clamp experiments, islets were dispersed into single cells immediately after preparation by incubation in Ca 2ϩ -free buffer followed by trituration. The cells were cultured in RPMI-1640 medium containing 10 mmol/l glucose and 2 mmol/l L-glutamine. Materials. -Conotoxin GVIA, SNX482, -agatoxin IVA, and stromatoxin-1 were purchased from Alomone Labs (Jerusalem, Israel) or the Peptide Institute (Osaka, Japan). Iberiotoxin (IbTX) was from Bachem (St. Helens, U.K.). All other chemicals were purchased from Sigma-Aldrich. Insulin secretion. Insulin secretion was measured as described elsewhere (15) . Briefly, batches of 10 -20 islets (in triplicates) were preincubated in 1 ml Krebs-Ringer buffer supplemented with 1 mmol/l glucose for 1 h followed by a 1-h incubation in 1 ml of test Krebs-Ringer buffer medium supplemented as indicated. Electrophysiology. Patch-clamp experiments were performed using an EPC-9 amplifier and Pulse software (HEKA, Lamprecht, Germany). All electrophysiological experiments were performed at 32-33°C using the standard or perforated-patch whole-cell configurations. Solutions. K ϩ currents were recorded in an extracellular solution composed of (mmol/l) 138 NaCl, 5.6 KCl, 2.6 CaCl 2 , 1.2 MgCl 2 , 5 HEPES, and 5 glucose (pH 7.4, adjusted with NaOH). For recording Na ϩ and Ca 2ϩ currents, 10 mmol/l tetraethylammonium (TEA) was added and NaCl correspondingly reduced. For Ca 2ϩ current measurements, 0.1 g/ml tetrodotoxin was added additionally. For Na ϩ current recordings, extracellular CaCl 2 was replaced equimolarly with MgCl 2 and 1 mmol/l CoCl 2 included in the medium.
The intracellular solution for K ϩ current measurements contained (mmol/l) 120 KCl, 1 MgCl 2 , 10 EGTA, 1 CaCl 2 , 10 HEPES, and 3 MgATP (pH 7.2, KOH). Na ϩ and Ca 2ϩ current measurements were made after equimolar substitution of KCl by CsCl. For capacitance measurements, the pipette solution contained (mmol/l) 125 Cs-glutamate, 10 CsCl, 10 NaCl, 1 MgCl 2 , 5 HEPES, 0.05 EGTA, 3 MgATP, and 0.1 cAMP (pH 7.2, CsOH). Glucose-and tolbutamide-induced electrical activity was recorded in the perforated-patch whole-cell configuration as previously reported (16) . Biocytin (0.5 mg/ml; Invitrogen) was added to all pipette solutions to facilitate subsequent establishment of cell identity. Immunocytochemistry. Immunolabeling with antibodies against insulin, glucagon, and somatostatin and detection of biocytin-loaded cells was performed essentially as described previously (17) . Quantitative RT-PCR. Gene expression profiling of ion-channel isoforms was performed by RT-qPCR on human islet total RNA (for details see the online appendix [available at http://dx.doi.org/10.2337/db07-0991]). Data analysis. All data points are expressed as means Ϯ SE of indicated number of experiments. All experiments were performed using islets/cells from at least two different donors. Inhibitory effects of channel blockers on glucose-induced insulin secretion are given after subtraction of basal release. Statistical significance was evaluated using Student's t test. A more detailed description of the experimental procedures is provided in the online appendix.
RESULTS

Voltage-gated K
؉ currents. The identity of all ␤-cells used for electrophysiological analysis in this study was confirmed by immunocytochemistry. Human ␤-cells thus identified had a membrane capacitance (C slow ) of 9.9 Ϯ 0.3 pF (n ϭ 207) (online appendix Fig. 1 ).
Voltage-gated K ϩ currents were elicited by 500 ms voltage-clamp depolarizations from a holding potential of Ϫ70 mV. Outward K ϩ currents became detectable during depolarizations to Ϫ30 mV and beyond (Fig. 1A) . The activation kinetics of the K ϩ current elicited by depolarization to ϩ10 mV was estimated using a Hodgkin-Huxley m 4 model. The time constant () of activation averaged 1.9 Ϯ 0.1 ms (n ϭ 31). In 26 of 31 cells, current inactivation was best described as the sum of two exponentials ( ϩ10 mV. In the remaining five cells, the inactivation could be well described using a single time constant of 1.8 Ϯ 0.3 s. In cells with a transient current component, a small "shoulder" in the current-voltage relationship (I-V) relationship was apparent at voltages between ϩ40 and ϩ60 mV (Fig. 1A and C) .
The peak outward current was sensitive to TEA; 1 and 10 mmol/l of this broad-spectrum K ϩ channel blocker inhibited 50 Ϯ 3% (n ϭ 9) and 83 Ϯ 3% (n ϭ 14), respectively (Fig. 1D) . The Kv2.1/2.2 antagonist stromatoxin-1 selectively inhibited the slowly inactivating outward current (Fig. 1E) . In a series of eight experiments, the sustained current component (measured at the end of a 250-ms depolarization to ϩ20 mV) was reduced by 45 Ϯ 6% (P Ͻ 0.001), while the peak current decreased only by 15 Ϯ 4% (P Ͻ 0.01).
The Ca 2ϩ channel blocker Co 2ϩ selectively abolished the transient current ( Fig. 2A) and removed the shoulder in the I-V relationship (Fig. 2B) . IbTX, a specific blocker of large-conductance Ca 2ϩ -activated K ϩ channels (BK channels), also selectively blocked the transient K ϩ current (Fig. 2C) , and its effect was indistinguishable from that of Co 2ϩ (compare Fig. 2A and C) . The IbTX-sensitive current was reconstructed by subtracting the current obtained in the presence of the blocker from that measured under control conditions. The isolated IbTX-sensitive current exhibited a bell-shaped voltage dependence with a peak of 41 Ϯ 11 pA/pF (n ϭ 9) at ϩ30 mV (Fig. 2D) , comparable with the 52 Ϯ 23 pA/pF (n ϭ 3) of the Co 2ϩ -sensitive current (not shown). Figure 2E (inset) shows the total and IbTX-resistant currents evoked by depolarization to Ϫ20 mV. Whereas the current before IbTX activated rapidly, the IbTX-insensitive current developed more slowly. Figure 2E summarizes the relationship between voltage and time constants of activation ( m ) of IbTX-sensitive and -resistant currents. The IbTX-sensitive and -insensitive currents elicited by depolarizations to ϩ10 mV inactivated with time constants of 22 Ϯ 6 ms (n ϭ 7) and 1.6 Ϯ 0.3 s (n ϭ 7), respectively (not shown). These values are comparable with the time constants for the fast and slowly inactivating components under control conditions described above. The magnitude of the IbTX-sensitive component at ϩ10 mV was ϳ50% of that of the IbTX-insensitive component (approximately one-third of the total), in good agreement with the fraction of the current showing rapid inactivation under control conditions (28%, see above).
The effects of the K ϩ channel blockers on ␤-cell electrical activity are shown in Fig. 3 . TEA (10 -20 mmol/l) increased the peak voltage of the action potentials induced by 6 mmol/l glucose (n ϭ 3) (Fig. 3A) or tolbutamide (100 mol/l; n ϭ 4) from Ϫ13 Ϯ 5 mV to 4 Ϯ 7 mV. The K V 2.1/2.2 blocker stromatoxin had weak effects on electrical activity; a significant increase in spike height was observed in only one of seven cells (Fig. 3B ) and the action potentials peaked at Ϫ21 Ϯ 3 mV in both the absence and presence of the blocker (n ϭ 4 for glucose, n ϭ 3 for tolbutamide). Addition of IbTX significantly increased the amplitude of glucose-induced action potentials in two of five cells (Fig.  3C ), whereas action potential firing was inhibited in the remaining three cells. The latter effect was accompanied by hyperpolarization and an increase in resting membrane conductance (n ϭ 2) (not shown), presumably reflecting activation of K ATP channels. When IbTX was tested in the presence of tolbutamide (100 mol/l), it consistently increased the amplitude of action potentials (n ϭ 3). Similar effects of IbTX were observed in current-injection experiments (online appendix Fig. 2A ).
Glucose at 6 mmol/l (a concentration attained postprandially in nondiabetic individuals [18] ) and 20 mmol/l stimulated insulin secretion 3.7-and 7.7-fold over basal (1 mmol/l), respectively (Fig. 3D) . TEA enhanced insulin secretion at 6 and 20 mmol/l glucose by 85 and 94%, respectively (Fig. 3D) . By contrast, stromatoxin had no significant effects on glucose-induced insulin secretion (Fig. 3E) , even when tested at a concentration of 1 mol/l (n ϭ 3 from one donor) (data not shown) (19) . We ascertained that stromatoxin remained a blocker of the delayed outward current under the experimental conditions used in the secretion assays (i.e., presence of BSA) (data not shown). Whereas IbTX was without effect at 20 mmol/l glucose (data not shown), it abolished the stimulatory effect of 6 mmol/l glucose (Fig. 3F) . When tested in the simultaneous presence of 6 mmol/l glucose and 0.1 mmol/l tolbutamide, however, IbTx stimulated insulin secretion by 73% (Fig. 3G) . Voltage-gated Na ؉ currents. When the pipettes were filled with a Cs ϩ -containing medium, voltage-clamp depolarizations to 0 mV elicited inward currents consisting of a very transient (ϳ2 ms) and a more slowly inactivating component (Fig. 4A ). Whereas the sustained component was suppressed by removal of extracellular Ca 2ϩ and addition of the broad-spectrum Ca 2ϩ channel blocker Co 2ϩ , the transient current was abolished by the selective Na ϩ channel blocker tetrodotoxin (TTX). Voltage-gated Na ϩ currents were activated by depolarizations to Ϫ30 mV and above and reached a maximal amplitude of 40 Ϯ 7 pA/pF at 0 mV (n ϭ 8) (Fig. 4B and C) . The voltage dependence of inactivation was characterized using a two-pulse protocol (Fig. 4D) . Inactivation was observed after prepulses positive to Ϫ80 mV. A Boltzmann fit yielded values for voltage of half-maximal inactivation (V h ) and slope factor (n h ) of Ϫ42 Ϯ 2 mV and 6 Ϯ 1 mV (n ϭ 9), respectively (Fig. 4E) .
We studied the effect of TTX on glucose-induced electrical activity (Fig. 4F) . In the presence of 6 mmol/l extracellular glucose, the cell-generated action potentials originating from ϳϪ60 mV and reaching up to 0 mV. Addition of TTX reversibly reduced the peak voltage of the action potentials from Ϫ12 Ϯ 2 mV to Ϫ24 Ϯ 3 mV (n ϭ 2). Similar effects were observed in current injection experiments (n ϭ 11) (online appendix Fig. 2B ). As shown in Fig.  4G , the TTX-sensitive Na ϩ current is important for glucose-induced insulin secretion, and secretion elicited by 6 and 20 mmol/l glucose was reduced by 70 and 55%, respectively, in the presence of TTX. Voltage-gated Ca 2؉ currents. Ca 2ϩ currents became detectable during depolarizations to Ϫ50 mV and peaked at 0 mV (Fig. 5A ), where the current density was 14 Ϯ 1 pA/pF (n ϭ 41). The activation kinetics of the Ca 2ϩ current was described using a Hodgkin-Huxley m 2 model. At 0 mV, the current activated with a time constant of 0.41 Ϯ 0.02 ms (n ϭ 28). The inactivation of the current was biphasic in most cells. The time constants for the rapid (comprising 35 Ϯ 3%) and slow components (43 Ϯ 3%) averaged 6.8 Ϯ 0.4 ms (n ϭ 25) and 65 Ϯ 15 ms (n ϭ 28), respectively.
The Ca 2ϩ channel subtypes underlying the voltage-gated Ca 2ϩ current were established using specific blockers. A representative recording is shown in Fig. 5B . In this experiment, the current was reduced by Ͼ90% by sequential application of first the L-type blocker isradipine alone, followed by a combination of isradipine and the P/Q-type inhibitor -agatoxin IVA and finally isradipine together with the T-type antagonist NNC 55-0396 (see also online appendix Fig. 3 ). Table 1 summarizes the inhibitory effects of the Ca 2ϩ channel blockers on the peak and integrated Ca 2ϩ currents evoked by depolarizations from Ϫ70 to 0 mV. The cumulative inhibitory effects of isradipine, -agatoxin IVA, and NNC 55-0396 amounted to 91%. The N-type blocker -conotoxin GVIA and the R-type blocker SNX-482 exerted negligible effects.
The voltage-dependent inactivation of the T-type Ca 2ϩ current was studied using a two-pulse protocol (Fig. 5C) .
The experiments were performed in the presence of isradipine and (in some cells) -agatoxin IVA to block Land P/Q-type Ca 2ϩ currents. A Boltzmann fit to the data points yielded values for V h and n h of Ϫ64 Ϯ 2 mV and 8 Ϯ 1 mV (n ϭ 13), respectively.
The currents flowing through the different channel subtypes were isolated by subtracting the responses recorded after application of the respective blockers from those obtained before blocker application (Fig. 5D) . I-V relationships for the total Ca 2ϩ current and the individual components are shown in Fig. 5E . T-type currents activated at Ϫ50 mV and reached a peak between Ϫ40 and Ϫ30 mV. L-type currents were first seen during depolarizations to Ϫ40 mV and reached a maximum between Ϫ20 and Ϫ10 mV. P/Q-type currents became significant only at potentials beyond Ϫ20 mV and peaked at 0 mV. The effect of -agatoxin IVA showed a slow onset and was maximal only 3-4 min after addition (not shown) (20) . Timedependent rundown of T-type Ca 2ϩ channels might therefore account for the apparent -agatoxin sensitivity of a current component at voltages more negative than Ϫ20 mV.
In insulin release experiments, isradipine inhibited glucose-stimulated (20 mmol/l) insulin release and reduced secretion below baseline levels (Fig. 6A) . By contrast, both SNX-482 and -conotoxin GVIA were without inhibitory effect, whereas -agatoxin IVA exerted a moderate inhibitory effect (Ϫ31%) (Fig. 6B) . The T-type channel blocker NNC 55-0396 was without effect on insulin secretion at 20 mmol/l glucose (not shown). When insulin secretion was evoked by 6 mmol/l glucose, addition of NNC 55-0396, -agatoxin IVA, and isradipine reduced glucose-stimulated release by 59, 71, and 100%, respectively ( Fig. 6C and D) , whereas -conotoxin remained ineffective (not shown). Figure 6E shows a cell electrically active at 20 mmol/l glucose. In all cells tested, isradipine completely suppressed electrical activity induced by glucose (6 or 20 mmol/l) (n ϭ 3) or tolbutamide (n ϭ 2). The T-type antagonist NNC 55-0396 also reduced action potential amplitude and frequency (Fig. 6F) . The peak voltage attained during the action potential was reduced from Ϫ28 Ϯ 2 mV under control conditions to Ϫ33 Ϯ 3 mV (P Ͻ 0.05) (n ϭ 3) in the presence of NNC 55-0396. Data obtained in membrane potential recordings echo those in the current-injection experiments (online appendix Fig. 2C  and D) . Capacitance measurements. Capacitance measurements were used to investigate depolarization-evoked exocytosis in human ␤-cells. While 20-ms depolarizations usually failed to evoke a clear (Ͼ10 fF) response, longer depolarization pulses triggered progressively larger capacitance increases (Fig. 7A) . In many ␤-cells, exocytosis continued beyond the depolarization. Figure 7B plots the increase evoked by the depolarization against pulse dura-tion. The average response during 500-ms depolarizations was 41 Ϯ 5 fF/pF. Figure 7C shows the relationship between the integrated Ca 2ϩ current and exocytosis. Exocytosis was small for integrated Ca 2ϩ currents with a charge of Ͻ0.4 pC/pF but then increased supralinearly with charge entry. The relationship was well described by a fourth-order polynomial function, compatible with cooperative binding of Ca 2ϩ to the Ca 2ϩ sensor of exocytosis (21) . We studied the voltage dependence of exocytosis by applying depolarizing pulses from Ϫ70 mV to voltages between Ϫ40 and ϩ40 mV (Fig. 7D) . Depolarizations to Ϫ20 mV or below were largely ineffective, but the responses then increased steeply, with a maximum being attained at 0 mV and a secondary reduction at more positive voltages. The observed voltage dependence of exocytosis most closely resembles that of the P/Q-type Ca 2ϩ channels (cf. Figure 5E ). We studied the effects of Ca 2ϩ channel blockers on depolarization-evoked exocytosis. Whereas -agatoxin exerted a strong inhibitory action on exocytosis evoked by a 500-ms depolarization to 0 mV, the effect of isradipine was weak (Fig. 7E) . On average, isradipine and -agatoxin reduced exocytosis by 31 Ϯ 15% (NS) (n ϭ 6) and 80 Ϯ 3% (P Ͻ 0.001) (n ϭ 5), respectively. Expression profiling of human islets. We quantified mRNA expression of voltage-gated ion channels in nine human islet preparations (online appendix Table 1 ). All known isoforms of Na ϩ channels were screened. Of the ␣-subunits, Na V 1.7 and Na V 1.6 dominated, while type 1␤ constitutes 80% of the total ␤-subunit expression. Of the Data are means Ϯ SE, unless otherwise indicated. Ca 2ϩ currents were measured during 100-ms depolarizations from Ϫ70 to 0 mV. The data are expressed as percent inhibition of control responses (*P Ͻ 0.001; †P Ͻ 0.01).
Ca
2ϩ channels, Ca V 3.2 (␣ 1G ; T type), Ca V 1.3 (␣ 1D ; L type), and Ca V 2.1 (␣ 1A ; P/Q type) isoforms were most abundant and account for 48, 28, and 12% of the transcript numbers, respectively. A selection of voltage-gated K ϩ channels based on Yan et al. (22) was screened. The expression of K V channels was dominated by K V 2.1 and K V 2.2 (24 and 73%, respectively). The ␣-subunit of the large conductance Ca 2ϩ -activated K ϩ channels (BK channels) was highly expressed, and of the ␤-subunits ␤ 2 predominated (80%).
DISCUSSION
We have characterized the voltage-gated membrane currents in identified human ␤-cells, their molecular composition, and their involvement in exocytosis, electrical activity, and glucose-induced insulin secretion. This was facilitated by the access to novel and selective blockers. Based on these data, we provide a model that outlines the respective roles of the different voltage-gated ion channels in stimulus secretion coupling in human ␤-cells. 
K
؉ currents. The voltage-gated K ϩ current in human ␤-cells consists of at least two different components. A transient component activates rapidly upon membrane depolarization, is dependent on Ca 2ϩ influx, and is blocked by IbTX. These properties suggest that it is carried by large-conductance Ca 2ϩ -activated K ϩ channels (BK channels). BK currents exhibited a typical bell-shaped voltage dependence, with decreasing amplitude at potentials Ͼ30 mV due to reduced Ca 2ϩ entry. It can be noted that the peak BK current is observed at a potential ϳ30 mV more positive than the peak Ca 2ϩ current (compare Figs. 2D and  5E ). This rightward shift reflects both the intrinsic voltage dependence of the channels, with (at fixed Ca 2ϩ levels) increased open probability at depolarized potentials (23) , and the increasing driving force for K ϩ entry. Similar to studies in chromaffin cells (24) and mouse ␤-cells (25) , BK currents were recorded despite the presence of a high concentration of EGTA in the intracellular solution. This suggests that BK channels and voltage-gated Ca 2ϩ channels are closely colocalized (26) . In mouse ␤-cells, BK channels do not play a major role in glucose-induced electrical activity or insulin secretion (27) . By contrast, in human ␤-cells blockade of BK channels increases spike amplitude. In some cells, addition of IbTX suppressed action potential firing. This effect appeared to result from an unexpected ability of IbTX to activate K ATP channels, which also accounts for the inhibition of glucose-induced insulin secretion. When insulin secretion was instead measured in the presence of tolbutamide, IbTX, as expected from the electrophysiological data, stimulated insulin secretion.
The second component of the K ϩ current developed with a delayed time course. This component was unaffected by Co 2ϩ and IbTX but inhibited by stromatoxin and TEA; inhibition by the latter compound was half maximal at ϳ1 mmol/l. The current is likely to be due to delayed rectifying K ϩ channels. K V 2.1 channels, which are dominant in rodent cells (28) , are also expressed in human ␤-cells (22) . However, at the mRNA level K V 2.2 channels are more abundant in human islets. In rodent cells, blockade of K V 2.1/2.2 channels stimulates insulin secretion (19, 28) . By contrast, in human islets the K V 2.1/2.2 blocker stromatoxin had no major effect on insulin release and electrical activity. It has been suggested that human ␤-cells also express A-type K ϩ currents (29), but we have so far detected such currents only in non-␤-cells in human islets (not shown). Collectively, these data suggest that BK channels are particularly important for spike repolarization. Their activation kinetics and voltage dependence make them ideally suited for this task. Na ؉ currents. In agreement with previous studies in human ␤-cells (10, 12) , but in marked contrast to mouse ␤-cells (30 -32) , the voltage-gated Na ϩ current could be activated from physiologically relevant membrane potentials (Ϫ70 mV and more positive). Using TTX, we could demonstrate the significance of these channels for action potential generation and insulin secretion. At the mRNA level, human islets express approximately equal amounts of Na v 1.6 and Na v 1.7. The latter channels are involved in nociception (33) , and Na v 1.7-specific antagonists are considered as analgesics. The possibility that such channels are involved in insulin secretion suggests that the use of such drugs may cause impaired insulin secretion as a side effect. Ca 2؉ currents and exocytosis. In agreement with previous studies (5, 11) , we show that L-type Ca 2ϩ channels are expressed in human ␤-cells. Blockade of L-type Ca 2ϩ channels using the selective antagonist isradipine leads to complete inhibition of glucose-induced insulin secretion. Our data suggest that the importance of L-type channels predominantly results from their essential role in the generation of electrical activity, whereas their role in exocytosis is modest (ϳ30%). The significance of L-type channels for the generation of electrical activity may reflect their voltage dependence: activation commences at voltages as negative as Ϫ40 mV (Fig. 5E) . The PCR data suggest that the L-type Ca 2ϩ channel is of the Ca V 1.3 (␣1D) subtype. The fact that the isradipine-sensitive current activates at more negative voltages in human than in mouse ␤-cells is consistent with this observation (34) .
Although expression of P/Q-type Ca 2ϩ channels in human ␤-cells has been reported earlier (8) , their relative contribution to the total Ca 2ϩ current and their function in stimulus secretion coupling have been unclear. We now show that P/Q-type Ca 2ϩ channels account for ϳ45% of the integrated whole-cell Ca 2ϩ current and that they play a critical role in depolarization-evoked exocytosis and glucose-induced insulin secretion, especially at low glucose concentrations (6 mmol/l). At variance with mouse ␤-cells (35), we found no electrophysiological evidence for the presence of R-type Ca 2ϩ channels. In fact, they are not at all expressed in human islets (online appendix Table 1) .
We further confirm that T-type Ca 2ϩ channels are also expressed (5) and contribute to electrical activity (10) in human ␤-cells. Using a recently developed, more selective antagonist (NNC55-9036) (see online appendix Fig. 3) , we obtained evidence that T-type channels are involved in insulin release evoked by 6 mmol/l glucose but not by 20 mmol/l glucose. We acknowledge that NNC55-9036 is not ideal in inhibiting non-T-type Ca 2ϩ currents also. However, the nonspecific effects (unlike those on the T type) were reversible. For secretion studies, islets were therefore preincubated for 15 min with the blocker, followed by a 10-min washout phase. In patch-clamp experiments using the same protocol, only the peak (T-type) Ca 2ϩ current was significantly reduced after pretreatment with NNC55-9036, whereas the sustained current (non-T type) was unaffected (see legend to online appendix Fig. 3 ). PCR analysis suggests that the T-type Ca 2ϩ current in human ␤-cells is of the Ca V 3.2 subtype. A model for electrical activity in human ␤-cells. Based on the findings in the present and previous studies, we propose that at physiological glucose concentrations (ϳ6 mmol/l) the closure of K ATP channel depolarizes the ␤-cell membrane to potentials above Ϫ55 mV. The activation of T-type (at voltages above Ϫ60 mV) and L-type Ca 2ϩ channels (above Ϫ50 mV) (Fig. 5E) initiates the action potential. During the upstroke of the action potential, voltage-gated Na ϩ channels also open (above Ϫ40 mV) ( Fig. 4B and C) , leading to a further acceleration of the upstroke and sufficient depolarization to activate P/Q-type Ca 2ϩ channels (above Ϫ20 mV). Ca 2ϩ influx via P/Q-type (and to a lesser extent L-type) Ca 2ϩ channels directly triggers exocytosis of insulin granules. The ␤-cell is repolarized by the activation of Ca 2ϩ -activated BK channels, with K V 2.1/2.2 channels playing only a minor role. The scenario outlined above is consistent with the observation that the inhibitory actions of TTX (see also 10), NNC55-0936, and -agatoxin are weaker at 20 than at 6 mmol/l glucose. As shown in Figs. 4F and 6F, inhibition of T-type Ca 2ϩ channels and Na ϩ channels reduces the action potential amplitude. A reduction of spike height by 15-20 mV (from the normal peak voltage of Ϫ10 to 0 mV) will result in Ͼ50% reduction of both the P/Q-type Ca 2ϩ current (Fig. 5E) and exocytosis (Fig. 7D) . Our data suggest that P/Q-type Ca 2ϩ channels are more tightly coupled to exocytosis than L-type Ca 2ϩ channels. Indeed, the exocytotic responses were small during depolarizations to Ϫ20 mV, a voltage associated with the maximum activation of the L-type Ca 2ϩ channels (Fig. 5E ). Concluding remarks. It is evident that human and mouse ␤-cells differ in many respects. Thus, some channels which are not considered functionally important in mouse ␤-cells (like the BK channels, T-and P/Q-type Ca 2ϩ channels, and voltage-gated Na ϩ channels) play critical roles in human ␤-cells. Conversely, R-type Ca 2ϩ channels and K V 2.1 channels appear less important in human cells than suggested by previous work in mice. As discussed above, this may have an impact on drug development. It seems unlikely that the differences between human and rodent ␤-cells are confined to ion channels. Indeed, there are examples of such differences in the literature. Whereas mouse ␤-cells depend on Glut2 for transmembrane glucose transport, human ␤-cells instead depend on Glut1 (36) . These discrepancies might also be relevant to the understanding of the genetics of type 2 diabetes. Clearly, a gene polymorphism associated with increased risk of type 2 diabetes is more likely to affect insulin secretion if the gene is expressed in human ␤-cells and vice versa.
